March 19, 2018
Cidara Therapeutics might have once-weekly treatment option for patients with difficult-to-treat and deadly invasive Candida infections
The results reported by Cidara Therapeutics, for its lead antifungal candidate rezafungin acetate, which met all of its primary objectives,…